Further study on the roles of the effector molecules of immunosuppressive macrophages induced by mycobacterial infection in expression of their suppressor function against mitogen-stimulated T cell proliferation

Clinical and Experimental Immunology

Volumn 108, Issue 1, 1997, Pages 26-33

  Maw, W W ^a   Shimizu, T ^a   Sato, K ^a   Tomioka, H ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Free fatty acids; Immunosuppressive macrophages; Mycobacterium avium intracellulare complex; Phosphatidylserine; Prostaglandins; Reactive nitrogen intermediates

Indexed keywords

DEXAMETHASONE; FATTY ACID; INDOMETACIN; MEPACRINE; NITRIC OXIDE; PHOSPHATIDYLSERINE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 0030889603     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-980.x     Document Type: Article

References (32)

1. Riley LW. Drug-resistant tuberculosis. Clin Infect Dis 1993; 17 (Suppl. 2):S422-6.
2. Benson CA. Disease due to Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis 1994; 18(Suppl. 3):S218-22.
3. Edwards D, Kirkpatrik CH. The immunology of mycobacterial diseases. Am Rev Respir Dis 1986; 134:1062-71.
4. Ellner JJ. Suppressor adherent cells in human tuberculosis. J Immunol 1978; 121:2573-9.
5. Klimpel GR, Heney CS. BCG-induced suppressor cells. I. Demonstration of macrophage-like suppressor cells that inhibit cytotoxic T cell generation in vitro. J Immunol 1978; 120:563-9.
6. Tomioka H, Saito H, Yamada Y. Characteristics of immunosuppresive macrophages induced in spleen cells by Mycobacterium avium complex infections in mice. J Gen Microbiol 1990; 136:965-74.
7. Tomioka H, Saito H, Sato K. Characteristics of immunosuppressive macrophages induced in host spleen cells by Mycobacterium avium complex and Mycobacterium tuberculosis infections in mice. Microbiol Immunol 1990; 34:283-97.
8. Tomioka H, Saito H. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J Leukocyte Biol 1992; 51:24-31.
9. Tomioka H, Sato K, Maw WW, Saito H. The role of tumor necrosis factor, interferon-γ, transforming growth factor-β, and nitric oxide in the expression of immunosuppressive functions of macrophages induced by Mycobacterium avium complex infection. J Leukocyte Biol 1995; 58:704-12.
10. Tomioka H, Kishimoto T, Maw WW. Phospholipids and reactive nitrogen intermediates collaborate in expression of the T cell mitogenesis-inhibitory activity of immunosuppressive macrophages induced in mycobacterial infection. Clin Exp Immunol 1996; 103:219-25.
11. Tomioka H, Maw WW, Sato K, Saito H. The role of tumor necrosis factor-α in combination with interferon-γ or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection. Immunology 1996; 88:61-67.
12. Hibbs JB Jr, Vavrin Z, Taintor Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235:473-6.
13. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169:1543-55.
14. Kita Y, Hirasawa K, Maeda M, Nishio M, Yoshida K. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur J Pharmacol 1994; 257:123-30.
15. Corbett JA, Tilton RC, Chang K et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992; 41:552-6.
16. 2 in endothelial cells. Biochem Pharmacol 1995; 49:57-63.
17. 2 inhibitor which prevents prostaglandin generation. Nature 1979; 278:456-9.
18. Vane JR. Inhibitors of prostaglandin, prostacycline, and thromboxane synthesis. Adv Prostaglandin Thromboxane Res 1978; 4:27-44.
19. Knowles RG, Salter M, Brooks SL, Moncada S. Anti-inflammatory glucocorticoids inhibit induction by endotoxin of nitric oxide synthase in the lung, liver, and aorta of the rat. Biochem Biophys Res Commun 1990; 172:1042-8.
20. Mills CD. Molecular basis of 'suppressor' macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 1991; 146:2719-23.
21. Fecho K, Maslonek KA, Coussons-Read ME, Dykstra LA, Lysle DT. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rat administered morphine in vivo. J Immunol 1994; 152:5845-52.
22. Angulo H, Rodriquez R, Garcia B, Mendina M, Navarro J, Subiza JL. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. J Immunol 1995; 155:15-26.
23. Upham JW, Strickland DH, Bilyk N, Robinson BWS, Holt PG. Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology 1995; 84:142-7.
24. Hemsworth GR, Kochan I. Secretion of antimycobacterial fatty acids by normal and activated macrophages. Infect Immun 1978; 19:170-7.
25. Brown RE, Steele RW, Marmer DJ, Hudson JL, Brewster MA. Fatty acids and the inhibition of mitogen induced lymphocyte transformation by leukemic serum. J Immunol 1983; 131:1011-6.
26. Richieri GV, Kleinfeld AM. Free fatty acid perturbation of transmembrane signalling in cytotoxic T lymphocytes. J Immunol 1989; 143:2302-10.
27. Kondo K, Kanai K. Host lipids in tuberculosis infection. I. Phospholipids. Kekkaku 1981; 56:1-9.
28. Gan H, Newman GW, Remold HG. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J Immunol 1995; 155:1304-15.
29. Caselli E, Baricordi OR, Melchiorri L, Bellini F, Ponzin D, Bruni A. Inhibition of DNA synthesis in peripheral blood mononuclear cells treated with phosphatidylserines containing unsaturated acyl chains. Immunopharmacology 1992; 23:205-13.
30. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-16.
31. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Ab1. J Exp Med 1995; 182:1545-56.
32. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149:4029-35.